Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Gullestad, L; Manhenke, C; Aarsland, T; Skardal, R; Fagertun, H; Wikstrand, J; Kjekshus, J
   Effect of metoprolol CR/XL on exercise tolerance in chronic heart failure - a substudy to the MERIT-HF trial
   EUROPEAN JOURNAL OF HEART FAILURE
   
   L. Gullestad et al., "Effect of metoprolol CR/XL on exercise tolerance in chronic heart failure - a substudy to the MERIT-HF trial", EUR J HE FA, 3(4), 2001, pp. 463-468
2. Moer, R; Myreng, Y; Molstad, P; Albertsson, P; Gunnes, P; Lindvall, B; Wiseth, R; Ytre-Arne, K; Kjekshus, J; Golf, S
   Stenting in small coronary arteries (SISCA) trial - A randomized comparison between balloon angioplasty and the heparin-coated beStent
   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
   
   R. Moer et al., "Stenting in small coronary arteries (SISCA) trial - A randomized comparison between balloon angioplasty and the heparin-coated beStent", J AM COL C, 38(6), 2001, pp. 1598-1603
3. Goldstein, S; Fagerberg, B; Hjalmarson, A; Kjekshus, J; Waagstein, F; Wedel, H; Wikstrand, J
   Metoprolol controlled release/extended release in patients with severe heart failure - Analysis of the experience in the MERIT-HF study
   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
   
   S. Goldstein et al., "Metoprolol controlled release/extended release in patients with severe heart failure - Analysis of the experience in the MERIT-HF study", J AM COL C, 38(4), 2001, pp. 932-938
4. Wilhelmsen, L; Pyorala, K; Wedel, H; Cook, T; Pedersen, T; Kjekshus, J
   Risk factors for a major coronary event after myocardial infarction in theScandinavian Simvastatin Survival Study (4S) - Impact of predicted risk onthe benefit of cholesterol-lowering treatment
   EUROPEAN HEART JOURNAL
   
   L. Wilhelmsen et al., "Risk factors for a major coronary event after myocardial infarction in theScandinavian Simvastatin Survival Study (4S) - Impact of predicted risk onthe benefit of cholesterol-lowering treatment", EUR HEART J, 22(13), 2001, pp. 1119-1127
5. Holm, T; Berge, RK; Andreassen, AK; Ueland, T; Kjekshus, J; Simonsen, S; Froland, S; Gullestad, L; Aukrust, P
   Omega-3 fatty acids enhance tumor necrosis factor-alpha levels in heart transplant recipients
   TRANSPLANTATION
   
   T. Holm et al., "Omega-3 fatty acids enhance tumor necrosis factor-alpha levels in heart transplant recipients", TRANSPLANT, 72(4), 2001, pp. 706-711
6. Alpert, JS; Thygesen, K; Antman, E; Bassand, JP; Apple, F; Armstrong, PW; Bassand, JP; de Luna, AB; Beller, G; Breithardt, G; Chaitman, BR; Clemmensen, P; Falk, E; Fishbein, MC; Galvani, M; Garson, A; Grines, C; Hamm, C; Hoppe, U; Jaffe, A; Katus, H; Kjekshus, J; Klein, W; Klootwijk, P; Lenfant, C; Levy, D; Levy, RI; Luepker, R; Marcus, F; Naslund, U; Ohman, M; Pahlm, O; Poole-Wilson, P; Popp, R; Pyorala, J; Ravkilde, J; Rehnquist, N; Roberts, W; Roberts, R; Roelandt, J; Ryden, L; Sans, S; Simoons, ML; Thygesen, K; Tunstall-Pedoe, H; Underwood, R; Uretsky, BF; Van de Werf, F; Voipio-Pulkki, LM; Wagner, G; Wallentin, L; Wijns, W; Wood, D; Sendon, JLL; Tendera, M
   Myocardial infarction redefined - A consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction (Reprinted from J Am Coll Cardiol, vol36, pg 959-69, 2000)
   CLINICAL CHEMISTRY
   
   J.S. Alpert et al., "Myocardial infarction redefined - A consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction (Reprinted from J Am Coll Cardiol, vol36, pg 959-69, 2000)", CLIN CHEM, 47(3), 2001, pp. 382-392
7. Aukrust, P; Gullestad, L; Aass, H; Fjeld, JG; Wikeby, L; Andreassen, AK; Ihlen, H; Simonsen, S; Kjekshus, J; Nitter-Hauge, S; Ueland, T; Froland, SS
   Increase in anti-inflammatory cytokine levels in chronic heart failure: A measure of treatment success or failure? Response
   CIRCULATION
   
   P. Aukrust et al., "Increase in anti-inflammatory cytokine levels in chronic heart failure: A measure of treatment success or failure? Response", CIRCULATION, 104(18), 2001, pp. E97-E98
8. Gullestad, L; Aass, H; Fjeld, JG; Wikeby, L; Andreassen, AK; Ihlen, H; Simonsen, S; Kjekshus, J; Nitter-Hauge, S; Ueland, T; Lien, E; Froland, SS; Aukrust, P
   Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure
   CIRCULATION
   
   L. Gullestad et al., "Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure", CIRCULATION, 103(2), 2001, pp. 220-225
9. Holven, KB; Holm, T; Aukrust, P; Christensen, B; Kjekshus, J; Andreassen, AK; Gullestad, L; Hagve, TA; Svilaas, A; Ose, L; Nenseter, MS
   Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects
   AMERICAN JOURNAL OF MEDICINE
   
   K.B. Holven et al., "Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects", AM J MED, 110(7), 2001, pp. 536-542
10. Dickstein, K; Kjekshus, J
    Comparison of baseline data, initial course, and management: Losartan versus captopril following acute myocardial infarction (The OPTIMAAL trial)
    AMERICAN JOURNAL OF CARDIOLOGY
    
    K. Dickstein e J. Kjekshus, "Comparison of baseline data, initial course, and management: Losartan versus captopril following acute myocardial infarction (The OPTIMAAL trial)", AM J CARD, 87(6), 2001, pp. 766
11. Holm, T; Andreassen, AK; Ueland, T; Kjekshus, J; Froland, SS; Kjekshus, E; Simonsen, S; Aukrust, P; Gullestad, L
    Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients
    AMERICAN JOURNAL OF CARDIOLOGY
    
    T. Holm et al., "Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients", AM J CARD, 87(6), 2001, pp. 815
12. Qi, W; Mathisen, P; Kjekshus, J; Simonsen, S; Bjornerheim, R; Endresen, K; Hall, C
    Natriuretic peptides in patients with aortic stenosis
    AMERICAN HEART JOURNAL
    
    W. Qi et al., "Natriuretic peptides in patients with aortic stenosis", AM HEART J, 142(4), 2001, pp. 725-732
13. Wedel, H; DeMets, D; Deedwania, P; Fagerberg, B; Goldstein, S; Gottlieb, S; Hjalmarson, A; Kjekshus, J; Waagstein, F; Wikstrand, J
    Challenges of subgroup analyses in multinational clinical trials: Experiences from the MERIT-HF trial
    AMERICAN HEART JOURNAL
    
    H. Wedel et al., "Challenges of subgroup analyses in multinational clinical trials: Experiences from the MERIT-HF trial", AM HEART J, 142(3), 2001, pp. 502-511
14. Gullestad, L; Ueland, T; Brunsvig, A; Kjekshus, J; Simonsen, S; Froland, SS; Aukrust, P
    Effect of metoprolol on cytokine levels in chronic heart failure - A substudy in the Metoprolol Controlled-Release Randomised Intervention Trial in Heart Failure (MERIT-HF)
    AMERICAN HEART JOURNAL
    
    L. Gullestad et al., "Effect of metoprolol on cytokine levels in chronic heart failure - A substudy in the Metoprolol Controlled-Release Randomised Intervention Trial in Heart Failure (MERIT-HF)", AM HEART J, 141(3), 2001, pp. 418-421
15. Alpert, JS; Antman, E; Apple, F; Armstrong, PW; Bassand, JP; de Luna, AB; Beller, G; Breithardt, G; Chaitman, BR; Clemmensen, P; Falk, E; Fishbein, MC; Galvani, M; Garson, A; Grines, C; Hamm, C; Jaffe, A; Katus, H; Kjekshus, J; Klein, W; Klootwijk, P; Lenfant, C; Levy, D; Levy, RI; Luepker, R; Marcus, F; Naslund, U; Ohman, M; Pahlm, O; Poole-Wilson, P; Popp, R; Alto, P; Pyorala, K; Ravkilde, J; Rehnquist, N; Roberts, W; Roberts, R; Roelandt, J; Ryden, L; Sans, S; Simoons, ML; Thygesen, K; Tunstall-Pedoe, H; Underwood, R; Uretsky, BF; Van de Werf, F; Voipio-Pulkki, LM; Wagner, G; Wallentin, L; Wijns, W; Wood, D
    Myocardial infarction redefined - A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    
    J.S. Alpert et al., "Myocardial infarction redefined - A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction", J AM COL C, 36(3), 2000, pp. 959-969
16. Latini, R; Tognoni, G; Maggioni, AP; Baigent, C; Braunwald, E; Chen, ZM; Collins, R; Flather, M; Franzosi, M; Kjekshus, J; Kober, L; Liu, LS; Peto, R; Pfeffer, M; Pizzetti, F; Santoro, E; Sleight, P; Swedberg, K; Tavazzi, L; Wang, W; Yusuf, S
    Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin - Systematic overview of individual data from 96,712 randomized patients
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    
    R. Latini et al., "Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin - Systematic overview of individual data from 96,712 randomized patients", J AM COL C, 35(7), 2000, pp. 1801-1807
17. Alpert, JS; Antman, E; Apple, F; Armstrong, PW; Bassand, JP; de Luna, AB; Beller, G; Breithardt, G; Chaitman, BR; Clemmensen, P; Falk, E; Fishbein, MC; Galvani, M; Garson, A; Grines, C; Hamm, C; Hoppe, U; Jaffe, A; Katus, H; Kjekshus, J; Klein, W; Klootwijk, P; Lenfant, C; Levy, D; Levy, RI; Luepker, R; Marcus, F; Naslund, U; Ohman, M; Pahlm, O; Poole-Wilson, P; Popp, R; Pyorala, K; Ravkilde, J; Rehnquist, N; Roberts, W; Roberts, R; Roelandt, J; Ryden, L; Sans, S; Simoons, ML; Thygesen, K; Tunstall-Pedoe, H; Underwood, R; Uretsky, BF; de Werf, FV; Voipio-Pulkki, LM; Wagner, G; Wallentin, L; Wijns, W; Wood, D
    Myocardial infarction redefined - A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction
    EUROPEAN HEART JOURNAL
    
    J.S. Alpert et al., "Myocardial infarction redefined - A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction", EUR HEART J, 21(18), 2000, pp. 1502-1513
18. Pedersen, TR; Kjekshus, J
    Statin drugs and the risk of fracture
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    
    T.R. Pedersen e J. Kjekshus, "Statin drugs and the risk of fracture", J AM MED A, 284(15), 2000, pp. 1921-1922
19. Hjalmarson, A; Goldstein, S; Fagerberg, B; Wedel, H; Waagstein, F; Kjekshus, J; Wikstrand, J; El Allaf, D; Vitovec, J; Aldershvile, J; Halinen, M; Dietz, R; Neuhaus, KL; Janosi, A; Thorgeirsson, G; Dunselman, PHJM; Gullestad, L; Kuch, J; Herlitz, J; Rickenbacher, P; Ball, S; Gottlieb, S; Deedwania, P
    Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure - The metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF)
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    
    A. Hjalmarson et al., "Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure - The metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF)", J AM MED A, 283(10), 2000, pp. 1295-1302
20. Qi, W; Kjekshus, J; Hall, C
    Differential responses of plasma atrial and brain natriuretic peptides to acute alteration in atrial pressure in pigs
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
    
    W. Qi et al., "Differential responses of plasma atrial and brain natriuretic peptides to acute alteration in atrial pressure in pigs", SC J CL INV, 60(1), 2000, pp. 55-63
21. Kjekshus, J
    Distribution of myocardial injury and its relation to epicardial ST-segment changes after coronary artery occlusion in the dog
    CARDIOVASCULAR RESEARCH
    
    J. Kjekshus, "Distribution of myocardial injury and its relation to epicardial ST-segment changes after coronary artery occlusion in the dog", CARDIO RES, 45(1), 2000, pp. 109-110
22. Pedersen, TR; Wilhelmsen, L; Faergeman, O; Strandberg, TE; Thorgeirsson, G; Troedsson, L; Kristianson, J; Berg, K; Cook, TJ; Haghfelt, T; Kjekshus, J; Miettinen, T; Olsson, AG; Pyorala, K; Wedel, H
    Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering
    AMERICAN JOURNAL OF CARDIOLOGY
    
    T.R. Pedersen et al., "Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering", AM J CARD, 86(3), 2000, pp. 257-262
23. Kjekshus, J; Gullestad, L
    Heart rate as a therapeutic target in heart failure
    EUROPEAN HEART JOURNAL SUPPLEMENTS
    
    J. Kjekshus e L. Gullestad, "Heart rate as a therapeutic target in heart failure", EUR H J SUP, 1(H), 1999, pp. H64-H69
24. Swedberg, K; Kjekshus, J; Snapinn, S
    Long-term survival in severe heart failure in patients treated with enalapril - Ten year follow-up of CONSENSUS I
    EUROPEAN HEART JOURNAL
    
    K. Swedberg et al., "Long-term survival in severe heart failure in patients treated with enalapril - Ten year follow-up of CONSENSUS I", EUR HEART J, 20(2), 1999, pp. 136-139
25. Anand, IS; Francis, G; Maseri, A; Milazzotto, F; Pepine, CJ; Yusuf, S; Beaufils, P; Ferrari, R; Poole-Wilson, PA; Remme, WJ; Schlepper, M; Tavazzi, L; Visioli, O; Zarco, P; Lubsen, J; Jacono, A; Kjekshus, J; Bruzzi, P; Marubini, E; Victor, N; De Giuli, F; Opasich, C; Pasini, E; Klein, W; Bounhoure, JP; Cohen, SA; Page, E; Zannad, F; Grosser, K; Rettig-Sturmer, G; Ciampricotti, R; de Boo, J; den Hartog, F; Huige, MC; Kragten, H; Penn, H; Visser, F; Bernardi, D; Caponnetto, S; Cardoni, C; Chiariello, M; Cobelli, F; Cucchini, F; De Ambroggi, L; Del Citerna, F; De Ponti, CL; Giannuzzi, P; Giordano, A; Giusti, C; Lotto, A; Maseri, A; Magnani, B; Rengo, F; Rengo, F; Scrutinio, D; Toso, M; Vergassola, R; Zanuttini, D; Llosa, C; Montero, JM; de la Calzada, CS; Soler, S; Zarco, P; Adamec, R; Martina, B; Noble, M; Sutton, G; Yellon, D
    Study on propionyl-L-carnitine in chronic heart failure
    EUROPEAN HEART JOURNAL
    
    I.S. Anand et al., "Study on propionyl-L-carnitine in chronic heart failure", EUR HEART J, 20(1), 1999, pp. 70-76
26. Herman, WH; Alexander, CM; Cook, JR; Boccuzzi, SJ; Musliner, TA; Pedersen, TR; Kjekshus, J; Pyorala, K
    Effect of simvastatin treatment on cardiovascular resource utilization in impaired pasting glucose and diabetes - Findings from the Scandinavian Simvastatin Survival Study
    DIABETES CARE
    
    W.H. Herman et al., "Effect of simvastatin treatment on cardiovascular resource utilization in impaired pasting glucose and diabetes - Findings from the Scandinavian Simvastatin Survival Study", DIABET CARE, 22(11), 1999, pp. 1771-1778
27. Hjalmarson, A; Goldstein, S; Fagerberg, B; Wedel, H; Waagstein, F; Kjekshus, J; Wikstrand, J; Hassle, A; Westergren, G; Hassle, A; Thimell, M; El Allaf, D; Vitovec, J; Aldershvile, J; Halinen, M; Dietz, R; Neuhaus, KL; Janosi, A; Thorgeirsson, G; Dunselman, P; Gullestad, L; Kuch, J; Herlitz, J; Rickenbacher, P; Ball, S; Gottlieb, S; Deedwania, P; Vandenhoven, G; Novakova, I; Danker, S; Lundstrom, M; Meyer-Sabellek, W; Balla, I; Sveinsdottir, M; Dorhout, B; Hildebrandt, A; Szczurko, I; Larsson, C; Bucher, E; Scott, E; Dwyer, D; Julian, DG; DeMets, DL; Chatterjee, K; Feyzi, J; Lehto, S; Karpati, P; Motz, W; Samuelsson, O; Viersma, JW; Andersson, B; Berthe, C; Boutefeu, JM; Boxho, G; Decroly, P; Derbaudrenghien, JP; El Allaf, D; Pirlet, J; Henry, P; Heyndrickx, G; Missault, L; Nannan, M; Timmermans, P; Vachiery, JL; Van Mieghem, W; Vandenbossche, JL; Dvorak, K; Herold, M; Hradec, J; Kana, A; Petr, P; Rybka, J; Smid, J; Svitil, P; Toman, J; Vitovec, J; Agner, E; Aldershvile, J; Amtorp, O; Egstrup, K; Eliasen, P; Gotzsche, CO; Hildebrandt, P; Johannesen, A; Kaiser-Nielsen, P; Nielsen, H; Nielsen, PE; Pedersen, F; Nielsen, JR; Skagen, K; Halinen, M; Honkanen, T; Hussi, E; Juvonen, J; Jaaskelainen, H; Rinne, J; Salonen, T; Andresen, D; Berwing, H; Dietz, R; Forster, A; Hauf, GF; Krosse, B; Luderitz, B; von Olshausen, KE; Schmailzl, KJG; Schwimmbeck, PL; Sigmund, M; Voller, H; Czuriga, I; Hetey, M; Janosi, A; Katona, A; Lengyel, M; Nyaradi, A; Rednik, A; Sandori, K; Szabo, P; Tarjan, J; Tenczer, J; Timar, S; Valyi, P; Veress, G; Zamolyi, K; Oze, B; Thorgeirsson, G; Thorgeirsson, G; Bernink, PJLM; Bredero, AC; Breedveld, RW; Breuls, PNWM; Bucx, JJJ; Cornel, JH; De Milliano, PAR; Dunselman, PHJM; Hamer, BJB; Holwerda, NL; Hoogsteen, J; Hoorntje, JCA; Kragten, JA; Liem, AH; Linssen, GCM; Michels, HR; Misier, ARR; Schaafsma, HJ; Sijbring, P; Taverne, RJT; Van Kempen, LHJ; Van Stralen, R; Van Veldhuisen, PJ; Veerhoek, MJ; Werter, CJPJ; Wesdorp, JCL; Willems, AR; Withagen, AJAM; Zwart, PAG; Bjornerheim, R; Dahle, M; Dickstein, K; Froland, GS; Gullestad, L; Gundersen, T; Hofsoy, K; Hole, TL; Johansen, T; Mannsverk, J; Nesje, P; Omland, TM; Sjodin, C; Smith, P; Tjonndal, HA; Vikesdal, O; Waage, K; Jaworska, K; Kolodziej, P; Kornacewicz-Jach, Z; Krzeminska-Pakula, M; Kuch, J; Piotrowski, JW; Piwowarska, W; Stogowski, A; Wodniecki, J; Wrabec, K; Ahlstrom, P; Ekdahl, S; Hemmingson, LO; Herlitz, J; Holmberg, L; Lernfelt, B; Nilsson, H; Widgren, B; Angman, K; Erne, P; Mohacsi, P; Polikar, R; Rickenbacher, P; Schlapfer, H; Batin, P; Berkin, KE; Callaghan, TS; Forfar, J; Frenneaux, M; Greenbaum, RA; Maltz, M; Murdoch, D; Reynolds, G; Stephens, J; Struthers, A; Swan, J; Tildesley, G; Abbasi, A; Alagona, P; Alderman, J; Alipour, M; Anderson, JL; Ansari, Z; Ashraf, M; Beanblossom, BT; Bennett, S; Benvenuti, D; Berk, MR; Bhalla, R; Bilazarian, SD; Browne, KF; Buchter, CM; Carlson, R; Carlson, CJ; Danisa, K; Dauber, I; DeWood, MA; Deedwania, P; Dennish, G; Denny, DM; DiBianco, R; Diller, PM; Dunlap, M; Dowd, K; Edmiston, A; El Shahawy, M; Elkayam, U; Farnham, J; Fenster, P; Friedman, S; Heywood, T; Galichia, JP; Geller, M; Ghali, JK; Gheorghiade, M; Giles, T; Gillespe, R; Goldberg, G; Goldberg, MC; Goldscher, DA; Gooden, GP; Goodman, M; Goodman, L; Gorwit, J; Gottlieb, SS; Gradman, A; Grech, D; Hack, T; Hall, JH; Hattenhauer, MT; Higginbotham, MB; Hutchins, S; Imburgia, M; Iteld, BJ; Jackson, B; Jafri, S; Jauch, W; Jennison, S; Kahn, BH; Kao, W; Kaplan, K; Karlsberg, R; Kennedy, HL; Kennedy, JJ; Kirkegaard, L; Kraus, DH; LaBresh, K; Lalonde, L; Lesser, MF; Levites, R; Levy, M; Lewis, RK; Loh, IK; Madyoon, H; Maislos, F; Mann, D; Maurice, GL; Nisar, A; Old, W; Pappas, JD; Phadke, K; Promisloff, S; Rashkow, AM; Reeves, B; Rosen, JH; Rotman, M; Saleem, T; Savran, SV; Shah, R; Shalev, Y; Shanes, JG; O'Shaughnessy, M; Silverman, B; Steingart, RM; Swenson, L; Syed, K; Thadani, U; Thorsen, RD; Tonkon, MJ; Touchon, R; Uhl, G; Vaska, KJ; Wagner, SG; Weaver, CJ; Weiss, RJ; Wickemeyer, WJ; Willens, HJ; Wilson, JR; Wright, R; Yellen, L
    Effect of metoprolol CR XL in chronic heart failure: Metoprolol CR XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
    LANCET
    
    A. Hjalmarson et al., "Effect of metoprolol CR XL in chronic heart failure: Metoprolol CR XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)", LANCET, 353(9169), 1999, pp. 2001-2007
28. Haffner, SM; Alexander, CM; Cook, TJ; Boccuzzi, SJ; Musliner, TA; Pedersen, TR; Kjekshus, J; Pyorala, K
    Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels - Subgroup analyses in the Scandinavian simvastatin survival study
    ARCHIVES OF INTERNAL MEDICINE
    
    S.M. Haffner et al., "Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels - Subgroup analyses in the Scandinavian simvastatin survival study", ARCH IN MED, 159(22), 1999, pp. 2661-2667
29. Dickstein, K; Kjekshus, J
    Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: The OPTIMAAL trial design
    AMERICAN JOURNAL OF CARDIOLOGY
    
    K. Dickstein e J. Kjekshus, "Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: The OPTIMAAL trial design", AM J CARD, 83(4), 1999, pp. 477-481
30. SIRNES PA; GOLF S; MYRENG Y; MOLSTAD P; ALBERTSSON P; MANGSCHAU A; ENDRESEN K; KJEKSHUS J
    SUSTAINED BENEFIT OF STENTING CHRONIC CORONARY-OCCLUSION - LONG-TERM CLINICAL FOLLOW-UP OF THE STENTING IN CHRONIC CORONARY-OCCLUSION (SICCO) STUDY
    Journal of the American College of Cardiology
    
    P.A. Sirnes et al., "SUSTAINED BENEFIT OF STENTING CHRONIC CORONARY-OCCLUSION - LONG-TERM CLINICAL FOLLOW-UP OF THE STENTING IN CHRONIC CORONARY-OCCLUSION (SICCO) STUDY", Journal of the American College of Cardiology, 32(2), 1998, pp. 305-310
31. FAERGEMAN O; KJEKSHUS J; COOK T; PYORALA K; WILHELMSEN L; THORGEIRSSON G; PEDERSEN TR
    DIFFERENCES IN THE TREATMENT OF CORONARY HEART-DISEASE BETWEEN COUNTRIES AS REVEALED IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S)
    European heart journal
    
    O. Faergeman et al., "DIFFERENCES IN THE TREATMENT OF CORONARY HEART-DISEASE BETWEEN COUNTRIES AS REVEALED IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S)", European heart journal, 19(10), 1998, pp. 1531-1537
32. RODEVAND O; BJORNERHEIM R; AAKHUS S; KJEKSHUS J
    LEFT-VENTRICULAR VOLUMES ASSESSED BY DIFFERENT NEW 3-DIMENSIONAL ECHOCARDIOGRAPHIC METHODS AND ORDINARY BIPLANE TECHNIQUE
    International journal of cardiac imaging
    
    O. Rodevand et al., "LEFT-VENTRICULAR VOLUMES ASSESSED BY DIFFERENT NEW 3-DIMENSIONAL ECHOCARDIOGRAPHIC METHODS AND ORDINARY BIPLANE TECHNIQUE", International journal of cardiac imaging, 14(1), 1998, pp. 55-63
33. GULLESTAD L; AASS H; ROSS H; UELAND T; GEIRAN O; KJEKSHUS J; SIMONSEN S; FOWLER M; KOBILKA B
    NEUROPEPTIDE-Y RECEPTOR-1 (NPY-Y1) EXPRESSION IN HUMAN HEART-FAILURE AND HEART-TRANSPLANTATION
    Journal of the autonomic nervous system
    
    L. Gullestad et al., "NEUROPEPTIDE-Y RECEPTOR-1 (NPY-Y1) EXPRESSION IN HUMAN HEART-FAILURE AND HEART-TRANSPLANTATION", Journal of the autonomic nervous system, 70(1-2), 1998, pp. 84-91
34. Klinge, R; Hystad, M; Kjekshus, J; Karlberg, BE; Djoseland, O; Aakvaag, A; Hall, C
    An experimental study of cardiac natriuretic peptides as markers of development of congestive heart failure
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
    
    R. Klinge et al., "An experimental study of cardiac natriuretic peptides as markers of development of congestive heart failure", SC J CL INV, 58(8), 1998, pp. 683-691
35. HAFFNER SM; ALEXANDER CM; BOCCUZZI SJ; COOK TJ; MUSLINER TA; PEDERSEN TR; KJEKSHUS J; PYORALA K
    IMPROVED SURVIVAL, REDUCED MAJOR CORONARY EVENTS AND FEWER REVASCULARIZATIONS IN SIMVASTATIN-TREATED 4S PATIENTS WITH IMPAIRED FASTING GLUCOSE
    Diabetes
    
    S.M. Haffner et al., "IMPROVED SURVIVAL, REDUCED MAJOR CORONARY EVENTS AND FEWER REVASCULARIZATIONS IN SIMVASTATIN-TREATED 4S PATIENTS WITH IMPAIRED FASTING GLUCOSE", Diabetes, 47, 1998, pp. 209-209
36. PEDERSEN TR; WILHELMSEN L; FAERGEMAN O; STRANDBERG T; THORGEIRSSON G; TROEDSSON L; KRISTIANSON J; COOK TJ; KJEKSHUS J
    EXTENDED FOLLOW-UP OF PATIENTS IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S) SHOWS INCREASED SURVIVAL BENEFIT OF SIMVASTATIN THERAPY
    Circulation
    
    T.R. Pedersen et al., "EXTENDED FOLLOW-UP OF PATIENTS IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S) SHOWS INCREASED SURVIVAL BENEFIT OF SIMVASTATIN THERAPY", Circulation, 98(17), 1998, pp. 2370-2370
37. FRANZOSI MG; SANTORO E; ZUANETTI G; BAIGENT C; COLLINS R; FLATHER M; KJEKSHUS J; LATINI R; LIU LS; MAGGIONI AP; SLEIGHT P; SWEDBERG K; TOGNONI G; YUSUF S; TAVAZZI L; BALL S; KOBER L; TORPPEDERSEN C; BRAUNWALD E; MOYE L; PFEFFER M; SANTORO L; POGUE J; WANG Y
    INDICATIONS FOR ACE-INHIBITORS IN THE EARLY TREATMENT OF ACUTE MYOCARDIAL-INFARCTION - SYSTEMATIC OVERVIEW OF INDIVIDUAL DATA FROM 100,000 PATIENTS IN RANDOMIZED TRIALS
    Circulation
    
    M.G. Franzosi et al., "INDICATIONS FOR ACE-INHIBITORS IN THE EARLY TREATMENT OF ACUTE MYOCARDIAL-INFARCTION - SYSTEMATIC OVERVIEW OF INDIVIDUAL DATA FROM 100,000 PATIENTS IN RANDOMIZED TRIALS", Circulation, 97(22), 1998, pp. 2202-2212
38. PEDERSEN TR; OLSSON AG; FAERGEMAN O; KJEKSHUS J; WEDEL H; BERG K; WILHELMSEN L; HAGHFELT T; THORGEIRSSON G; PYORALA K; MIETTINEN T; CHRISTOPHERSEN B; TOBERT JA; MUSLINER TA; COOK TJ
    LIPOPROTEIN CHANGES AND REDUCTION IN THE INCIDENCE OF MAJOR CORONARY HEART-DISEASE EVENTS IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY
    Circulation
    
    T.R. Pedersen et al., "LIPOPROTEIN CHANGES AND REDUCTION IN THE INCIDENCE OF MAJOR CORONARY HEART-DISEASE EVENTS IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY", Circulation, 97(15), 1998, pp. 1453-1460
39. AUKRUST P; UELAND T; MULLER F; ANDREASSEN AK; NORDOY I; AAS H; KJEKSHUS J; SIMONSEN S; FROLAND SS; GULLESTAD L
    ELEVATED CIRCULATING LEVELS OF C-C CHEMOKINES IN PATIENTS WITH CONGESTIVE-HEART-FAILURE
    Circulation
    
    P. Aukrust et al., "ELEVATED CIRCULATING LEVELS OF C-C CHEMOKINES IN PATIENTS WITH CONGESTIVE-HEART-FAILURE", Circulation, 97(12), 1998, pp. 1136-1143
40. GULLESTAD L; HAYWOOD G; AASS H; ROSS H; YEE G; UELAND T; GEIRAN O; KJEKSHUS J; SIMONSEN S; BISHOPRIC N; FOWLER M
    ANGIOTENSIN-II RECEPTOR SUBTYPE AT(1) AND AT(2) EXPRESSION AFTER HEART-TRANSPLANTATION
    Cardiovascular Research
    
    L. Gullestad et al., "ANGIOTENSIN-II RECEPTOR SUBTYPE AT(1) AND AT(2) EXPRESSION AFTER HEART-TRANSPLANTATION", Cardiovascular Research, 38(2), 1998, pp. 340-347
41. BRAEKKEN SK; ENDRESEN K; RUSSELL D; BRUCHER R; KJEKSHUS J
    INFLUENCE OF GUIDEWIRE AND CATHETER TYPE ON THE FREQUENCY OF CEREBRALMICROEMBOLIC SIGNALS DURING LEFT-HEART CATHETERIZATION
    The American journal of cardiology
    
    S.K. Braekken et al., "INFLUENCE OF GUIDEWIRE AND CATHETER TYPE ON THE FREQUENCY OF CEREBRALMICROEMBOLIC SIGNALS DURING LEFT-HEART CATHETERIZATION", The American journal of cardiology, 82(5), 1998, pp. 632-637
42. PEDERSEN TR; KJEKSHUS J; PYORALA K; OLSSON AG; COOK TJ; MUSLINER TA; TOBERT JA; HAGHFELT T
    EFFECT OF SIMVASTATIN ON ISCHEMIC SIGNS AND SYMPTOMS IN THE SCANDINAVIAN-SIMVASTATIN-SURVIVAL-STUDY (4S)
    The American journal of cardiology
    
    T.R. Pedersen et al., "EFFECT OF SIMVASTATIN ON ISCHEMIC SIGNS AND SYMPTOMS IN THE SCANDINAVIAN-SIMVASTATIN-SURVIVAL-STUDY (4S)", The American journal of cardiology, 81(3), 1998, pp. 333-335
43. ANDREASSEN AK; KVERNEBO K; JORGENSEN B; SIMONSEN S; KJEKSHUS J; GULLESTAD L
    EXERCISE CAPACITY IN HEART-TRANSPLANT RECIPIENTS - RELATION TO IMPAIRED ENDOTHELIUM-DEPENDENT VASODILATION OF THE PERIPHERAL MICROCIRCULATION
    The American heart journal
    
    A.K. Andreassen et al., "EXERCISE CAPACITY IN HEART-TRANSPLANT RECIPIENTS - RELATION TO IMPAIRED ENDOTHELIUM-DEPENDENT VASODILATION OF THE PERIPHERAL MICROCIRCULATION", The American heart journal, 136(2), 1998, pp. 320-328
44. KJEKSHUS J; PEDERSEN TR
    USE OF STATINS - COST-EFFECTIVENESS WAS STUDIED IN 4S STUDY
    BMJ. British medical journal
    
    J. Kjekshus e T.R. Pedersen, "USE OF STATINS - COST-EFFECTIVENESS WAS STUDIED IN 4S STUDY", BMJ. British medical journal, 315(7122), 1997, pp. 1619-1620
45. KJEKSHUS J; PEDERSEN TR; PYORALA K; OLSSON AG
    EFFECT OF SIMVASTATIN ON ISCHEMIC SIGNS AND SYMPTOMS IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S)
    Journal of the American College of Cardiology
    
    J. Kjekshus et al., "EFFECT OF SIMVASTATIN ON ISCHEMIC SIGNS AND SYMPTOMS IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S)", Journal of the American College of Cardiology, 29(2), 1997, pp. 7181-7181
46. SCHWARTZ JS; BOCCUZZI SJ; MURRAY JF; ROEHM JB; COOK JR; GLICK H; KINOSIAN B; PEDERSEN T; KJEKSHUS J
    COST-EFFECTIVENESS OF LDL-C REDUCTION IN MEDICARE MANAGED CARE CHD PATIENTS - IMPLICATIONS FROM THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY(4S)
    Journal of the American College of Cardiology
    
    J.S. Schwartz et al., "COST-EFFECTIVENESS OF LDL-C REDUCTION IN MEDICARE MANAGED CARE CHD PATIENTS - IMPLICATIONS FROM THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY(4S)", Journal of the American College of Cardiology, 29(2), 1997, pp. 7672-7672
47. GULLESTAD L; MYERS J; BJORNERHEIM R; BERG KJ; DJOSELAND O; HALL C; LUND K; KJEKSHUS J; SIMONSEN S
    GAS-EXCHANGE AND NEUROHUMORAL RESPONSE TO EXERCISE - INFLUENCE OF THEEXERCISE PROTOCOL
    Medicine and science in sports and exercise
    
    L. Gullestad et al., "GAS-EXCHANGE AND NEUROHUMORAL RESPONSE TO EXERCISE - INFLUENCE OF THEEXERCISE PROTOCOL", Medicine and science in sports and exercise, 29(4), 1997, pp. 496-502
48. REMME WJ; CLELAND JGF; DARGIE H; ERDMANN E; FERRARI R; KJEKSHUS J; KOMAJDA M; POOLEWILSON PA; RIEGGER G; SOLERSOLER J; TAVAZZI L; SWEDBERG K; WAAGSTEIN F
    THE TREATMENT OF HEART-FAILURE
    European heart journal
    
    W.J. Remme et al., "THE TREATMENT OF HEART-FAILURE", European heart journal, 18(5), 1997, pp. 736-753
49. RODEVAND O; BJORNERHEIM R; KOLBJORNSEN O; IHLEN H; KJEKSHUS J
    LEFT-VENTRICULAR MASS ASSESSED BY 3-DIMENSIONAL ECHOCARDIOGRAPHY USING ROTATIONAL ACQUISITION
    Clinical cardiology
    
    O. Rodevand et al., "LEFT-VENTRICULAR MASS ASSESSED BY 3-DIMENSIONAL ECHOCARDIOGRAPHY USING ROTATIONAL ACQUISITION", Clinical cardiology, 20(11), 1997, pp. 957-962
50. PYORALA K; PEDERSEN TR; KJEKSHUS J; FAERGEMAN O; OLSSON AG; THORGEIRSSON G
    CHOLESTEROL-LOWERING WITH SIMVASTATIN IMPROVES PROGNOSIS OF DIABETIC-PATIENTS WITH CORONARY HEART-DISEASE - A SUBGROUP ANALYSIS OF THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S) (VOL 20, PG 614, 1997)
    Diabetes care
    
    K. Pyorala et al., "CHOLESTEROL-LOWERING WITH SIMVASTATIN IMPROVES PROGNOSIS OF DIABETIC-PATIENTS WITH CORONARY HEART-DISEASE - A SUBGROUP ANALYSIS OF THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S) (VOL 20, PG 614, 1997)", Diabetes care, 20(6), 1997, pp. 1048-1048
51. PYORALA K; PEDERSEN TR; KJEKSHUS J; FAERGEMAN O; OLSSON AG; THORGEIRSSON G
    CHOLESTEROL-LOWERING WITH SIMVASTATIN IMPROVES PROGNOSIS OF DIABETIC-PATIENTS WITH CORONARY HEART-DISEASE - A SUBGROUP ANALYSIS OF THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S)
    Diabetes care
    
    K. Pyorala et al., "CHOLESTEROL-LOWERING WITH SIMVASTATIN IMPROVES PROGNOSIS OF DIABETIC-PATIENTS WITH CORONARY HEART-DISEASE - A SUBGROUP ANALYSIS OF THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S)", Diabetes care, 20(4), 1997, pp. 614-620
52. AASER E; GULLESTAD L; TOLLOFSRUD S; LUNDBERG J; HALL C; DJOSELAND O; KJEKSHUS J; FORFANG K
    EFFECT OF BOLUS INJECTION VERSUS CONTINUOUS-INFUSION OF FUROSEMIDE ONDIURESIS AND NEUROHORMONAL ACTIVATION IN PATIENTS WITH SEVERE CONGESTIVE-HEART-FAILURE
    Scandinavian journal of clinical & laboratory investigation
    
    E. Aaser et al., "EFFECT OF BOLUS INJECTION VERSUS CONTINUOUS-INFUSION OF FUROSEMIDE ONDIURESIS AND NEUROHORMONAL ACTIVATION IN PATIENTS WITH SEVERE CONGESTIVE-HEART-FAILURE", Scandinavian journal of clinical & laboratory investigation, 57(4), 1997, pp. 361-367
53. JOHANNESSON M; JONSSON B; KJEKSHUS J; OLSSON AG; PEDERSEN TR; WEDEL H
    COST-EFFECTIVENESS OF SIMVASTATIN TREATMENT TO LOWER CHOLESTEROL LEVELS IN PATIENTS WITH CORONARY HEART-DISEASE
    The New England journal of medicine
    
    M. Johannesson et al., "COST-EFFECTIVENESS OF SIMVASTATIN TREATMENT TO LOWER CHOLESTEROL LEVELS IN PATIENTS WITH CORONARY HEART-DISEASE", The New England journal of medicine, 336(5), 1997, pp. 332-336
54. PEDERSEN TR; KJEKSHUS J; BERG K; FAERGEMAN O; MIETTINEN T; OLSSON AG
    LIPID CHANGES AND REDUCTIONS IN THE INCIDENCE OF MAJOR CORONARY HEART-DISEASE EVENTS IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S)
    Atherosclerosis
    
    T.R. Pedersen et al., "LIPID CHANGES AND REDUCTIONS IN THE INCIDENCE OF MAJOR CORONARY HEART-DISEASE EVENTS IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S)", Atherosclerosis, 130, 1997, pp. 21-21
55. BERG K; DAHLEN G; CHRISTOPHERSEN B; COOK T; KJEKSHUS J; PEDERSEN T
    LP(A) LIPOPROTEIN LEVEL PREDICTS SURVIVAL AND MAJOR CORONARY EVENTS IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY
    Clinical genetics
    
    K. Berg et al., "LP(A) LIPOPROTEIN LEVEL PREDICTS SURVIVAL AND MAJOR CORONARY EVENTS IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY", Clinical genetics, 52(5), 1997, pp. 254-261
56. ERIKSSON SV; KJEKSHUS J; ENEROTH P; SWEDBERG K
    NEOPTERIN, TUMOR-NECROSIS-FACTOR, C-REACTIVE PROTEIN AND PROSTAGLANDIN-E2 IN PATIENTS WITH SEVERE CONGESTIVE-HEART-FAILURE TREATED WITH ENALAPRIL
    Circulation
    
    S.V. Eriksson et al., "NEOPTERIN, TUMOR-NECROSIS-FACTOR, C-REACTIVE PROTEIN AND PROSTAGLANDIN-E2 IN PATIENTS WITH SEVERE CONGESTIVE-HEART-FAILURE TREATED WITH ENALAPRIL", Circulation, 96(8), 1997, pp. 1798-1798
57. SCHWARTZ JS; BROCCUZZI SJ; GLICK H; COOK JR; KINOSIAN B; DAVIS L; PEDERSEN TR; KJEKSHUS J
    COST-EFFECTIVENESS OF LDL-C REDUCTION IN DIABETIC CHD PATIENTS - IMPLICATIONS FROM THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S)
    Circulation
    
    J.S. Schwartz et al., "COST-EFFECTIVENESS OF LDL-C REDUCTION IN DIABETIC CHD PATIENTS - IMPLICATIONS FROM THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S)", Circulation, 96(8), 1997, pp. 2827-2827
58. AUKRUST P; UELAND T; AASS H; MULLER F; ANDREASSEN AK; KJEKSHUS J; FROLAND SS; SIMONSEN S; GULLESTAD L
    RAISED CIRCULATING LEVELS OF C-C CHEMOKINES IN PATIENTS WITH CHRONIC HEART-FAILURE
    Circulation
    
    P. Aukrust et al., "RAISED CIRCULATING LEVELS OF C-C CHEMOKINES IN PATIENTS WITH CHRONIC HEART-FAILURE", Circulation, 96(8), 1997, pp. 3595-3595
59. PEDERSEN TR; KJEKSHUS J; OLSSON AG; COOK TJ
    4S RESULTS SUPPORT AHA GUIDELINES TO REDUCE LDL-CHOLESTEROL TO LESS-THAN 100 MG DL IN PATIENTS WITH CHD/
    Circulation
    
    T.R. Pedersen et al., "4S RESULTS SUPPORT AHA GUIDELINES TO REDUCE LDL-CHOLESTEROL TO LESS-THAN 100 MG DL IN PATIENTS WITH CHD/", Circulation, 96(8), 1997, pp. 4019-4019
60. MIETTINEN TA; PYORALA K; OLSSON AG; MUSLINER TA; COOK TJ; FAERGEMAN O; BERG K; PEDERSEN T; KJEKSHUS J
    CHOLESTEROL-LOWERING THERAPY IN WOMEN AND ELDERLY PATIENTS WITH MYOCARDIAL-INFARCTION OR ANGINA-PECTORIS - FINDINGS FROM THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S)
    Circulation
    
    T.A. Miettinen et al., "CHOLESTEROL-LOWERING THERAPY IN WOMEN AND ELDERLY PATIENTS WITH MYOCARDIAL-INFARCTION OR ANGINA-PECTORIS - FINDINGS FROM THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S)", Circulation, 96(12), 1997, pp. 4211-4218
61. HJALMARSON A; GOLDSTEIN S; FAGERBERG B; WEDEL H; KJEKSHUS J; WAAGSTEIN F; ELALLAF D; VITOVEC J; ALDERSHVILE J; HALINEN M; DIETZ R; NEUHAUS KL; JANOSI A; THORGEIRSSON G; DUNSELMAN PHJM; GULLESTAD L; KUCH J; HERLITZ J; RICKENBACHER P; BALL SG; GOTTLIEB S; DEEDWANIA P; CHATTERJEE K; DEMETS D; JULIAN D; LEHTO S; MOTZ W; SAMUELSSON O; ANDERSSON B
    RATIONALE, DESIGN, AND ORGANIZATION OF THE METOPROLOL CR XL RANDOMIZED INTERVENTION TRIAL IN HEART-FAILURE (MERIT-HF)/
    The American journal of cardiology
    
    A. Hjalmarson et al., "RATIONALE, DESIGN, AND ORGANIZATION OF THE METOPROLOL CR XL RANDOMIZED INTERVENTION TRIAL IN HEART-FAILURE (MERIT-HF)/", The American journal of cardiology, 80(9B), 1997, pp. 54-58
62. NGUYEN KN; AURSNES I; KJEKSHUS J
    INTERACTION BETWEEN ENALAPRIL AND ASPIRIN ON MORTALITY AFTER ACUTE MYOCARDIAL-INFARCTION - SUBGROUP ANALYSIS OF THE COOPERATIVE NEW SCANDINAVIAN ENALAPRIL SURVIVAL STUDY-II (CONSENSUS-II)
    The American journal of cardiology
    
    K.N. Nguyen et al., "INTERACTION BETWEEN ENALAPRIL AND ASPIRIN ON MORTALITY AFTER ACUTE MYOCARDIAL-INFARCTION - SUBGROUP ANALYSIS OF THE COOPERATIVE NEW SCANDINAVIAN ENALAPRIL SURVIVAL STUDY-II (CONSENSUS-II)", The American journal of cardiology, 79(2), 1997, pp. 115-119
63. SNIDERMAN AD; PEDERSEN T; KJEKSHUS J
    PUTTING LOW-DENSITY LIPOPROTEINS AT CENTER STAGE IN ATHEROGENESIS
    The American journal of cardiology
    
    A.D. Sniderman et al., "PUTTING LOW-DENSITY LIPOPROTEINS AT CENTER STAGE IN ATHEROGENESIS", The American journal of cardiology, 79(1), 1997, pp. 64
64. GULLESTAD L; MYERS J; NODDELAND H; BJORNERHEIM R; DJOSELAND O; HALL C; GEIRAN O; KJEKSHUS J; SIMONSEN S
    INFLUENCE OF THE EXERCISE PROTOCOL ON HEMODYNAMIC, GAS-EXCHANGE, AND NEUROHUMORAL RESPONSES TO EXERCISE IN HEART-TRANSPLANT RECIPIENTS
    The Journal of heart and lung transplantation
    
    L. Gullestad et al., "INFLUENCE OF THE EXERCISE PROTOCOL ON HEMODYNAMIC, GAS-EXCHANGE, AND NEUROHUMORAL RESPONSES TO EXERCISE IN HEART-TRANSPLANT RECIPIENTS", The Journal of heart and lung transplantation, 15(3), 1996, pp. 304-313
65. GULLESTAD L; HAYWOOD G; ROSS H; BJORNERHEIM R; GEIRAN O; KJEKSHUS J; SIMONSEN S; FOWLER M
    EXERCISE CAPACITY OF HEART-TRANSPLANT RECIPIENTS - THE IMPORTANCE OF CHRONOTROPIC INCOMPETENCE
    The Journal of heart and lung transplantation
    
    L. Gullestad et al., "EXERCISE CAPACITY OF HEART-TRANSPLANT RECIPIENTS - THE IMPORTANCE OF CHRONOTROPIC INCOMPETENCE", The Journal of heart and lung transplantation, 15(11), 1996, pp. 1075-1083
66. KJEKSHUS J; SWEDBERG K
    TREATMENT OF HEART-FAILURE
    Journal of internal medicine
    
    J. Kjekshus e K. Swedberg, "TREATMENT OF HEART-FAILURE", Journal of internal medicine, 239(4), 1996, pp. 335-343
67. SIRNES PA; GOLF S; MYRENG Y; MOLSTAD P; EMANUELSSON H; ALBERTSSON P; BREKKE M; MANGSCHAU A; ENDRESEN K; KJEKSHUS J
    STENTING IN CHRONIC CORONARY-OCCLUSION (SICCO) - A RANDOMIZED, CONTROLLED TRIAL OF ADDING STENT IMPLANTATION AFTER SUCCESSFUL ANGIOPLASTY
    Journal of the American College of Cardiology
    
    P.A. Sirnes et al., "STENTING IN CHRONIC CORONARY-OCCLUSION (SICCO) - A RANDOMIZED, CONTROLLED TRIAL OF ADDING STENT IMPLANTATION AFTER SUCCESSFUL ANGIOPLASTY", Journal of the American College of Cardiology, 28(6), 1996, pp. 1444-1451
68. KJEKSHUS J; PEDERSEN TR; TOBERT JA
    LIPID-LOWERING THERAPY FOR PATIENTS WITH OR AT RISK OF CORONARY-ARTERY DISEASE
    Current opinion in cardiology
    
    J. Kjekshus et al., "LIPID-LOWERING THERAPY FOR PATIENTS WITH OR AT RISK OF CORONARY-ARTERY DISEASE", Current opinion in cardiology, 11(4), 1996, pp. 418-427
69. ABERNATHY GT; ABRAMS J; AKHTAR S; ALBITAR I; AMIDI M; ANAND IS; ARNOLD JMO; ASHTON T; AUBREY B; AUGER P; BABB J; BAIGRIE R; BAIRD MG; BAITZ T; BARBER NC; BARBOUR DJ; BARR DM; BASU AK; BAUGHMAN KL; BECKHAM V; BEKHEITSAAD S; BERKSON DM; BERTOGLIO M; BESSOUDO R; BEAUDOIN J; BHASKAR G; BINDER A; BLOOMFIELD D; BODINE K; BOEHMER JP; BORGERSEN K; BORTS D; BOUCHARD G; BOURASSA MG; BOUTROS G; BOZEK B; BRISBIN D; BROPHY J; BROSSOIT R; BROWN E; BROWN J; BRUINSMA N; BURTON G; CAMERON A; CAMPBELL R; CAMPEAU J; CAMPOS EE; CARDELLO FP; CARTER RP; CHAN YK; CHARLES FR; CHAUDHRY MA; CHIARAMIDA A; CHIARAMIDA S; CHOHAN A; CHRISTIE LG; CLEMSON BS; COLLIN R; COOK TH; COPEN DL; COSSETT J; COSTANTINO T; CRAWFORD MH; CROKE RP; CROWELL R; DAMOURS G; DAGENAIS GR; DANISA K; DAVIDSON S; DAVIES ML; DAVIES R; DAVIES RA; DELAROCHELLIERE R; DELEON AC; DELAGE F; DENES P; DENNISH GW; DENNY DM; DEVILLA MA; DEYOUNG JP; DHURANDHAR RW; DIBNERDUNLAP M; DODEK A; DOHERTY JE; DOMINGUEZ J; DUBBIN J; DUFTON J; EFFRON MB; ELSHERIF N; ELADASARI B; FLY D; ERICSON K; FAHRENHOLTZ D; FAST A; FELL DA; FISHMAN S; FITCHETT D; FLEG JL; FLINT E; FOLGER JS; FOLKINS D; FORKER AD; FOWLES RE; FRAKER TD; FRANCIS G; FRERKING TR; FRIESINGER GC; FULOP JC; GAGNON J; GAMBLE L; GANJAVI F; GARROU BW; GERVAIS PB; GHEORGHIADE M; GILBERT L; GILLIE E; GLATTER TR; GODLEY ML; GOERES M; GOLDBERGER MH; GOLLAPUDI A; GOODE JE; GOODMAN LS; GORDON R; GOSSARD D; GOSSELIN G; GOULET C; GRANT C; GRAETTINGER WF; GREENE JG; GREENWOOD PV; GREGORATOS G; GREGORY JJ; GRODEN DL; GROVER J; GUDAPATI R; GUESS MA; GUPTA SC; HABIB N; HACK I; HAMILTON WP; HANKEY TL; HANNA M; HARPER D; HARRIS DE; HASSAPOYANNES CA; HATHEWAY RJ; HEINSIMER J; PEQUIGNOT MH; HEISELMAN DE; HESS AR; HICKNER J; HICKEY JE; HIGGINS T; HIGGINSON L; HILL L; HOBBS RE; HONOS G; HORNER BA; HORWITZ L; HSIEH A; HSUEH JT; HUBBARD J; HUGHES DF; HUI W; IMRIE JR; JACOBS MH; JARMUKLI N; JOHNSON TH; JOHNSTONE D; JUTILA CK; KADRI N; KAHL FR; KAIMAL PK; KARNEGIS J; KAY R; KELLY KJ; KENEFICK G; KENNELLY BM; KENT E; KHAN AH; KHANIJO V; KHOURI M; KINLOCH D; KIRLIN PC; KIWAN GS; KLINE MD; KOHN RM; KOILPILLAI C; KORNDER JM; KOUZ S; KUMAR VA; KUMAR U; KUNTZ A; KURITZKY RA; KURUVILLA G; KWOK KK; LADER E; LAFOREST M; LAFORGE D; LALONDE G; LALONDE L; LANG RM; LATOUR Y; LAWAL O; LEBLANC MH; LEE AB; LEE RW; LEGAULT C; LEMAY M; LENIS JHF; LEPAGE S; LETARTE P; LEVESQUE C; LEVINOFFROTH SN; LEWIS BK; LIPSHUTZ H; LOUNGANI RR; LOWERY ML; LUBELL DL; LUCARIELLO R; LUGORODRIGUEZ JE; LUI C; LUTTERODT AT; LUTZ L; MACHEL T; MACINA G; MACLELLAN K; MAGNAN O; MANSURI M; MANYARI DE; MALLIS GI; MARR D; MAST DJ; MATHEW J; MCBARRON FD; MCINTYRE KM; MCLEAN RW; MCMAHON DP; MERCIER M; METHE M; MILLER AB; MINKOWITZ J; MILTON JR; MIZGALA HF; MOHANTY PK; MOHIUDDIN S; MONTERO A; MOOKHERJEE S; MORRIS A; MORRIS L; MORRISON J; MOTEN M; NAFZIGER A; NAIR PH; NAWAZ S; NEIMAN JC; NUTTING P; NGUYENPHO HT; OBRIEN TK; OKELLY RL; OREILLY MV; OKERSON D; PATEL G; PANDE PN; PAPA LA; PATRICK L; PAYNE RM; PERRY G; PHILBIN EF; PIERPONT G; PITT WA; POIRIER C; POLLAK EM; POPIO K; POULIN JF; PROBST PA; PRUNEAU G; PU C; PURAM BS; PUTATUNDA B; QUINN B; RABKIN SW; RACINE N; RACO DL; RADANT L; RADFORD MJ; RADWANY S; RAJACHAR M; RAMANATHAN KB; RASHKOW A; RAUSCH DC; READ L; REDDY KR; REID R; RICH MW; RICCI AJ; RICHMAN HG; RILEY A; RIM DA; RINNE C; ROBERGE G; ROBERTS DK; ROBINSON V; RODEHEFFER RT; ROSENSTEIN R; ROTH DL; ROTHBART R; ROULEAU JL; RUBLE P; SACCO J; SAFFORD RE; SALMON D; SAHAY BM; SARMA RJ; SAYEED MAR; SCHICK EC; SCHROEDER GS; SEIFERT M; SENARATNE MPJ; SESTIER F; SHAH A; SHANES JG; SHEESLEY K; SILVERMAN A; SHIVA T; SHRESTHA DD; SILVER MA; SILVERBERG L; SIMARD L; SINGH BN; SMALL RS; SMITH MR; SMITH S; SOCHOWSKI RA; SOUTHERN RF; SRIDHARAN MR; STHILAIRE R; STEIN M; STEWART JW; STILLABOWER ME; SULLIVAN BHM; STURROCK WA; SUSSEX BA; SWAN J; SWENSON L; TALBOT P; TALIBI T; TAMILIA M; TAN A; TANSER PH; TARRY L; TEO KK; THADANI U; THAGIRISA S; THOMPSON B; THORNTON R; TIMMIS GC; TOBIN M; TOMMASO C; TOREN M; TSUYUKI R; TUREK M; UTLEY K; VANDERBUSH EJ; VANVOORHEES L; VENTURA H; VERTES G; VIZEL S; WAGNER KR; WAGNER S; WEEKS A; WEINGERT ME; WEINSTEIN C; WEISS MM; WEISS R; WICKEMEYER W; WIELGOZ A; WILLENS HJ; WILLIAMS WL; WONG D; YAROWS SA; YAO L; SHALEV Y; YOUNG JB; YOUSEFIAN M; ZAJAC EJ; ZATUCHNI J; ZIPERMAN DB; ZOBLE RG; ZONERAICH S; GORLIN R; SLEIGHT P; COHN JN; COLLINS R; DEYKIN D; HENNEKENS C; KJEKSHUS J; SMITH TW; TOGNONI G; COLLINS JF; WILLIFORD WO; FYE C; SATHER R; JOLLY MK; HELD CP; VERTER J; YUSUF S; EGAN D; GARG R; JOHNSTONE DE; MONTAGUE T; BRISTOW D; ENGELHARDT HT; GENT M; HOOD WB; JONES S; MEIER P; PITT B; WATERS D; ARNOLD JMO; BAKER A; BARNHILL S; CAREW B; HAGAR S; LIUNI C; MARTIN S; MILES R; ARTHUR MM; FELDBUSH MW; HIGHFIELD DA; HOBBINS TE; KURZ R; LEVITON SP; LIBONATI JP; MOORE M; PEREZ E; MILLS P; GELLER N; HUNSBERGER S; GOLD J; HUANG PC; BURNS A; CALEB H; CLINE DR; HARRIS S; HOCKENBROCK R; HORNEY RA; JADWIN LM; KING J; SEXTON P; SPENCE ME; CHACON F; GAGNE W; MAPLE S; MARTINEZ G
    RATIONALE, DESIGN, IMPLEMENTATION, AND BASE-LINE CHARACTERISTICS OF PATIENTS IN THE DIG TRIAL - A LARGE, SIMPLE, LONG-TERM TRIAL TO EVALUATE THE EFFECT OF DIGITALIS ON MORTALITY IN HEART-FAILURE
    Controlled clinical trials
    
    G.T. Abernathy et al., "RATIONALE, DESIGN, IMPLEMENTATION, AND BASE-LINE CHARACTERISTICS OF PATIENTS IN THE DIG TRIAL - A LARGE, SIMPLE, LONG-TERM TRIAL TO EVALUATE THE EFFECT OF DIGITALIS ON MORTALITY IN HEART-FAILURE", Controlled clinical trials, 17(1), 1996, pp. 77-97
70. KJEKSHUS J
    TREATING THE DIABETIC PATIENT WITH CORONARY-DISEASE
    European heart journal
    
    J. Kjekshus, "TREATING THE DIABETIC PATIENT WITH CORONARY-DISEASE", European heart journal, 17(9), 1996, pp. 1298-1301
71. JONSSON B; JOHANNESSON M; KJEKSHUS J; OLSSON AG; PEDERSEN TR; WEDEL H
    COST-EFFECTIVENESS OF CHOLESTEROL-LOWERING - RESULTS FROM THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S)
    European heart journal
    
    B. Jonsson et al., "COST-EFFECTIVENESS OF CHOLESTEROL-LOWERING - RESULTS FROM THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S)", European heart journal, 17(7), 1996, pp. 1001-1007
72. RODEVAND O; BJORNERHEIM R; KJEKSHUS J
    LEFT-VENTRICULAR MASS ASSESSED BY 3-DIMENSIONAL ECHOCARDIOGRAPHY USING ROTATIONAL ACQUISITION
    Circulation
    
    O. Rodevand et al., "LEFT-VENTRICULAR MASS ASSESSED BY 3-DIMENSIONAL ECHOCARDIOGRAPHY USING ROTATIONAL ACQUISITION", Circulation, 94(8), 1996, pp. 4020-4020
73. PEDERSEN TR; KJEKSHUS J; BERG K; OLSSON AG; WILHELMSEN L; WEDEL H; PYORALA K; MIETTINEN T; HAGHFELT T; FAERGEMAN O; THORGEIRSSON G; JONSSON B; SCHWARTZ JS; THOMSEN H; NORDENO E; THOMSEN B; LYNGBORG K; ANDERSEN GS; NIELSEN F; TALLERUPHUUS U; MOGENSEN M; EGSTRUP K; SIMONSEN EH; SIMONSEN I; VEJBYCHRISTENSEN H; SOMMER L; EIDNER PO; KLARHOLT E; HENRIKSEN A; MELLEMGAARD K; LAUNBERG J; FRUERGAARD P; NIELSEN L; MADSEN EB; IBSEN H; ANDERSEN U; THYRRING L; THOMASSEN K; JENSEN G; RASMUSSEN SL; SKOV N; HANSEN KN; LARSEN ML; HAASTRUP B; HJAERE I; THURO A; SORENSEN K; LETH A; MUNCH M; WORCK R; NIELSEN B; THORN AG; PEDERSENBJERREGAARD O; FOURNAISE B; SIGURD B; ENK B; NIELSEN H; JACOBSEN L; SVENDSEN TL; NOEGHOLM A; MUNTER H; HAUNSO S; GRANDE P; ERIKSEN C; NIELSEN HH; PINDBORG T; PINDBORG J; TOST H; CHRISTIANSEN BD; OPPENHAGEN M; EGEDE F; HVIDT S; KJAERBY T; FLEMMING L; KLAUSEN I; VANHANEN H; STRANDBERG T; HOLTTA K; PASTERNAK A; OKSA H; SIITONEN L; RIMPI R; KESANIEMI A; JUUSTILA H; NISSILA A; SAVOLAINEN M; LILJA M; RANTALA A; RANTALA M; LAINE L; MANTYMAA L; NISSILA A; VIRKKALA L; EBELING T; HELIN M; LEHTO S; PALOMAKI P; RANTALA A; VOUTILAINEN E; MIETTINEN H; RAISANEN R; SALOKANNEL A; JANTUNEN A; HOGNASON J; THORSTEINSDOTTIR G; SIGURDSSON G; SVERRISSON JT; HANSTEEN V; KJELSBERG F; BERGET K; PETTERSEN R; RANDI E; HOLM T; GUNDERSEN T; ASLAKEN B; ANDRESEN EH; TORSVIK H; PETTERSEN R; FABER A; INDREBO T; OSE A; ROTERUD T; HOLSTLARSEN L; WAAGE K; HOLSTLARSEN E; HAEREM JW; AUKRUST P; TORP R; MAUSETH K; HALLARAKER A; GERDTS E; GRADEK G; NYGARD O; VANGEN EM; HANSEN HS; RESFSUM AM; LISTERUD S; GUNDERSRUD B; STENE AM; AAKERVIK O; KLUKKEN B; LORAAS A; FOSS PO; HAGA A; THORESEN L; DRIVENES A; LEM P; GABRIELSEN F; HESTAD S; RODE R; HAUG BK; SKJELVAN G; ELDORSEN E; YTREARNE K; RASMUSSEN K; NERMOEN I; GJESTVANG FT; CHRISTIANSEN L; WALBERG K; TJONNDAL HA; KULSENG B; ROKSETH R; NERGARD TV; ROE MO; TENSTAD O; LOFSNES IL; BERGSRUD U; MELBERG TH; VONBRANDIS C; HEGRENES L; BARVIK S; WOIE L; ABRAHAMSEN AM; AARSLAND T; SVANES H; NOER G; NORDLIE KE; HANEDALEN AE; OVERSKEID K; SANDVEI P; JOHANSEN A; JOHANSEN T; HOLM T; LARSEN CB; OSTHOLM E; HEGRESTAD S; REIKVAM A; SOGNEN E; STILIANOY E; HAWKES L; HOFF S; NORDVIK R; JORGENSEN C; HJERMANN I; LEREN P; NARVESTAD A; FAUSA D; GJESTVANG FT; BERGET K; NORDLAND B; BRUNMARK P; BIORKLUND H; FORSBERG H; NILSSON J; BERGSTROM B; LAAKSONEN I; VESTERMARK MB; MASCHER G; HAMMARSTROM E; TROSELL K; KARLSSON L; HALLSTROM L; STJERNA A; SLETTE MK; BERGLUND KP; LINDE B; AHLMARK G; SAETRE H; AHLBERG G; SUNDKVIST K; LOFMARK R; GUSTAFSSON PE; MICHAELI EW; GUSTAFSSON E; SKARFORS E; RUTER G; AKESSON L; WAGNER F; LJUNGDAHL L; WAGNER V; EDHAG O; VOURISALO D; HJELMSELL H; LUNDKVIST L; ANGMAN K; OLSSON A; SVENSSON O; KUYLENSTIERNA J; FRISENETTEFICH K; BERGMAN E; STROMBLAD H; JENSEN S; JONSSON E; LEVIN C; ODEBERG H; BENGTSSON PO; HOLMESSON E; HEDSTAND H; BOJO L; OBERG S; PERSSON S; CLINE C; LEKSELL H; WIRENSTAM UB; MOBERG B; EKSTRAND AB; NICOL P; MALMROS B; SAAW J; ARCINI N; KOBOSKO J; ANEVIK IG; GYLAND F; LUNDH B; WENNERHOLM M; OLSSON C; KJELLBERG J; FABIANSON K; FRASER T; BERGKVIST I; OLSSON AG; BERGDAHL B; FLUUR K; WARJESTAM S; SVENSSON KA; EKHOLM L; TOREBO E; RYBERG A; FRISELL J; HEDMAN A; VALLRUP L; ANDERSEN G; SUNDSTROM M; ALBERY K; FAGHER B; THULIN T; SVENSTAM I; NORRBY A; JAUP B; SVENSSON L; BJURMAN A; SKOGLUND E; DAHL G; KJELLSTROM T; JUHLIN P; SJOOBOQUIST M; SJOGREN A; LOOGNA E; JANSSON T; FRIDEN J; NILSSON O; ANDERSSON PO; HENRIKSSON C; ELLSTROM J; BRODERSSON H; LUNDQUIST L; ASLUND M; BOMAN K; JANSSON JH; NORRFORS B; HOGLUND C; LUNDBLAD M; EJDEBACK J; MALMBERG K; HOGSTROM S; STAHL L; LEIJD B; FALKENBERG C; BERGSTEN L; STROM S; ENGSTROM AC; PETZ I; LILJEFORS I; WENNERSTROM L; WIKLUND O; LINDEN T; BERGH CH; JONSTED K; BONNIER B; LUNDIN Y; MOLLER BH; LYCKSELL M; SODERSTROM M; HANSSON E; GILLGREN L; HALLEN C; STAKEBERG H; BORRETZEN J; HEDEN B; ANDERSSON K; JOHNSON O; SLUNGA L; JENSEN S; ELANDER B; LIDELL C; ANDERSSON PE; MARKLUND E; DAHLEN M; RUCKER F; LOFQVIST M; WANNBERG B; LIM BH; LARSSON O; ANDERSSON G; HANSSON A; GOWENIUS M; UGGELDAHL I; URSING D; HAMMARLUND P; TSUPPUKA E; MALMBERG L; GORANSSON K; HASSELGREN P; INBERG KM; PETTERSON S; ARLIN A; ULVENSTAM G; JOHANSSON S; WALLIN I; DUDAS K; ANDREASSON M; TORELUND G; LOVHEIM O; HEMMINGSON LO; GRUNDSTROM I; JULIAN DG; FURBERG C; THOMPSON S; LUBSEN J; SMITH WM; HUTTUNEN J; ROMO M; THYGESEN K; LEHTO S; MIETTINEN H; CROW R; CHRISTOPHERSEN B; BUCHMAN M; GRAN T; COOK J; GOMES D; BOCCUZZI S; COOK T; KRISTIANSON K
    CHOLESTEROL-LOWERING AND THE USE OF HEALTH-CARE RESOURCES - RESULTS OF THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY
    Circulation
    
    T.R. Pedersen et al., "CHOLESTEROL-LOWERING AND THE USE OF HEALTH-CARE RESOURCES - RESULTS OF THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY", Circulation, 93(10), 1996, pp. 1796-1802
74. PEDERSEN TR; BERG K; COOK TJ; FAERGEMAN O; HAGHFELT T; KJEKSHUS J; MIETTINEN T; MUSLINER TA; OLSSON AG; PYORALA K; THORGEIRSSON G; TOBERT JA; WEDEL H; WILHELMSEN L
    SAFETY AND TOLERABILITY OF CHOLESTEROL-LOWERING WITH SIMVASTATIN DURING 5 YEARS IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY
    Archives of internal medicine
    
    T.R. Pedersen et al., "SAFETY AND TOLERABILITY OF CHOLESTEROL-LOWERING WITH SIMVASTATIN DURING 5 YEARS IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY", Archives of internal medicine, 156(18), 1996, pp. 2085-2092
75. DICKSTEIN K; CHANG P; WILLENHEIMER R; HAUNSO S; REMES J; HALL C; KJEKSHUS J
    COMPARISON OF THE EFFECTS OF LOSARTAN AND ENALAPRIL ON CLINICAL STATUS AND EXERCISE PERFORMANCE IN PATIENTS WITH MODERATE OR SEVERE CHRONICHEART-FAILURE
    Journal of the American College of Cardiology
    
    K. Dickstein et al., "COMPARISON OF THE EFFECTS OF LOSARTAN AND ENALAPRIL ON CLINICAL STATUS AND EXERCISE PERFORMANCE IN PATIENTS WITH MODERATE OR SEVERE CHRONICHEART-FAILURE", Journal of the American College of Cardiology, 26(2), 1995, pp. 438-445
76. CLELAND JG; ERDMANN E; FERRARI R; HESS OM; POOLEWILSON PA; REMME WJ; RIEGGER G; SOLERSOLER J; SWEDBERG KB; TAVAZZI L; WAAGSTEIN F; DARGIE HJ; KJEKSHUS J; POULEUR H
    GUIDELINES FOR THE DIAGNOSIS OF HEART-FAILURE
    European heart journal
    
    J.G. Cleland et al., "GUIDELINES FOR THE DIAGNOSIS OF HEART-FAILURE", European heart journal, 16(6), 1995, pp. 741-751
77. PEDERSEN TR; KJEKSHUS J; BERG K; HAGHFELT T; FAERGEMAN O; THORGEIRSSON G; PYORALA K; MIETTINEN T; WILHELMSEN L; OLSSON AG; WEDEL H
    BASE-LINE SERUM-CHOLESTEROL AND TREATMENT EFFECT IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S)
    Lancet
    
    T.R. Pedersen et al., "BASE-LINE SERUM-CHOLESTEROL AND TREATMENT EFFECT IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S)", Lancet, 345(8960), 1995, pp. 1274-1275
78. COLLINS R; PETO R; FLATHER M; PARISH S; SLEIGHT P; CONWAY M; PIPILIS A; BAIGENT C; BARNETT D; BOISSEL JP; BUDAJ A; CAIRNS J; CEREMUZYNSKI L; COHEN AF; DEBACKER G; DIAZ R; DIENSTL F; DOVE P; FRANZOSI MG; GENONI M; HALON DA; HEIKKILA J; HENNEKENS C; HORGAN J; HUNT D; KALA R; KARATZAS N; KEECH A; KELTAI M; KJEKSHUS J; KORNITZER M; KOSTER R; LANDLESS P; LECHLEITNER P; LEIZOROVICZ A; LEWIS BS; LUNDKVIST L; MACMAHON S; MAGGIONI A; MALACRIDA R; MEYER T; MOCCETTI T; OCALLAGHAN D; PAOLASSO E; PIEGAS LS; REIKVAM A; RIDKER P; RYAN T; SCHRODER R; SEABRAGOMES R; SOUSA JEMR; TOGNONI G; TURPIE A; VALENTIN V; VARIGOS J; WHITE H; WILHELMSEN L; WOODS K; YUSUF S; PIOMBO A; GUZMAN LA; MONTENEGRO DC; IRUSTA G; SCHNEIDER RA; CUNEO C; CHAMORRO BH; ESPINOSA GE; MORENO M; RIOS MM; DOLL R; FOX K; JULIAN D; MEIER P; SANDOYA E; PEREZ JE
    ISIS-4 - A RANDOMIZED FACTORIAL TRIAL ASSESSING EARLY ORAL CAPTOPRIL,ORAL MONONITRATE, AND INTRAVENOUS MAGNESIUM-SULFATE IN 58,050 PATIENTS WITH SUSPECTED ACUTE MYOCARDIAL-INFARCTION
    Lancet
    
    R. Collins et al., "ISIS-4 - A RANDOMIZED FACTORIAL TRIAL ASSESSING EARLY ORAL CAPTOPRIL,ORAL MONONITRATE, AND INTRAVENOUS MAGNESIUM-SULFATE IN 58,050 PATIENTS WITH SUSPECTED ACUTE MYOCARDIAL-INFARCTION", Lancet, 345(8951), 1995, pp. 669-685
79. PYORALA K; PEDERSEN TR; KJEKSHUS J
    THE EFFECT OF CHOLESTEROL-LOWERING WITH SIMVASTATIN ON CORONARY EVENTS IN DIABETIC-PATIENTS WITH CORONARY HEART-DISEASE
    Diabetes
    
    K. Pyorala et al., "THE EFFECT OF CHOLESTEROL-LOWERING WITH SIMVASTATIN ON CORONARY EVENTS IN DIABETIC-PATIENTS WITH CORONARY HEART-DISEASE", Diabetes, 44, 1995, pp. 35-35
80. KJEKSHUS J; PEDERSEN TR; PYORALA K
    IMPACT OF HYPERTENSION, DIABETES AND SMOKING ON THE EFFECT OF SIMVASTATIN AN CORONARY EVENT IN CORONARY HEART-DISEASE PATIENTS
    Circulation
    
    J. Kjekshus et al., "IMPACT OF HYPERTENSION, DIABETES AND SMOKING ON THE EFFECT OF SIMVASTATIN AN CORONARY EVENT IN CORONARY HEART-DISEASE PATIENTS", Circulation, 92(8), 1995, pp. 86-86
81. PEDERSEN TR; KJEKSHUS J
    EFFECT OF CONCOMITANT THERAPY ON THE RISK REDUCTIONS PRODUCED BY SIMVASTATIN IN CHD PATIENTS
    Circulation
    
    T.R. Pedersen e J. Kjekshus, "EFFECT OF CONCOMITANT THERAPY ON THE RISK REDUCTIONS PRODUCED BY SIMVASTATIN IN CHD PATIENTS", Circulation, 92(8), 1995, pp. 939-939
82. SCHWARTZ JS; KJEKSHUS J; PEDERSEN TR
    IMPACT OF CHOLESTEROL-LOWERING ON RESOURCE USE AND COST AMONG PATIENTS WITH CORONARY HEART-DISEASE (CHD) - RESULTS FROM 45
    Circulation
    
    J.S. Schwartz et al., "IMPACT OF CHOLESTEROL-LOWERING ON RESOURCE USE AND COST AMONG PATIENTS WITH CORONARY HEART-DISEASE (CHD) - RESULTS FROM 45", Circulation, 92(8), 1995, pp. 2434-2434
83. PEDERSEN TR; KJEKSHUS J; BOCCUZZI SJ; EPSTEIN RS
    CLINICAL AND RESOURCE UTILIZATION BENEFITS OF THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S) APPLIED TO THE US POPULATION
    Circulation
    
    T.R. Pedersen et al., "CLINICAL AND RESOURCE UTILIZATION BENEFITS OF THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S) APPLIED TO THE US POPULATION", Circulation, 92(8), 1995, pp. 2485-2485
84. PEDERSEN TR; KJEKSHUS J; PYORALA K; WILHELMSEN L; HAGHFELT T
    EFFECT OF SIMVASTATIN ON SURVIVAL AND CORONARY MORBIDITY IN CORONARY HEART-DISEASE PATIENTS 65 OR OLDER
    Circulation
    
    T.R. Pedersen et al., "EFFECT OF SIMVASTATIN ON SURVIVAL AND CORONARY MORBIDITY IN CORONARY HEART-DISEASE PATIENTS 65 OR OLDER", Circulation, 92(8), 1995, pp. 3225-3225
85. KENDALL MJ; LYNCH KP; HJALMARSON A; KJEKSHUS J
    BETA-BLOCKERS AND SUDDEN CARDIAC DEATH
    Annals of internal medicine
    
    M.J. Kendall et al., "BETA-BLOCKERS AND SUDDEN CARDIAC DEATH", Annals of internal medicine, 123(5), 1995, pp. 358-367
86. KJEKSHUS J; PEDERSEN TR
    REDUCING THE RISK OF CORONARY EVENTS - EVIDENCE FROM THE SCANDINAVIANSIMVASTATIN SURVIVAL STUDY (4S)
    The American journal of cardiology
    
    J. Kjekshus e T.R. Pedersen, "REDUCING THE RISK OF CORONARY EVENTS - EVIDENCE FROM THE SCANDINAVIANSIMVASTATIN SURVIVAL STUDY (4S)", The American journal of cardiology, 76(9), 1995, pp. 64-68
87. DOWNS JR; GOTTO A; CLEARFIELD M; GORDON D; MANOLIO T; GOLDBOURT U; KAPLINSKY E; MOYE L; SACKS F; PFEFFER M; HAWKINS CM; BRAUNWALD E; FRANZOSI MG; MAGGIONI A; TOGNONI G; ROBINS S; RUBINS H; SIMES J; KEECH A; MACMAHON S; TONKIN A; YUSUF S; FLATHER M; COLLINS R; KEECH A; ARMITAGE J; BAIGENT C; PETO R; SLEIGHT P; KNATTERUD G; KJEKSHUS J; PEDERSEN T; WILHELMSEN L; ROUSSOUW J; PROBSTFIELD J; COBBE S; MACFARLANE P; SHEPHERD J
    PROTOCOL FOR A PROSPECTIVE COLLABORATIVE OVERVIEW OF ALL CURRENT AND PLANNED RANDOMIZED TRIALS OF CHOLESTEROL TREATMENT REGIMENS
    The American journal of cardiology
    
    J.R. Downs et al., "PROTOCOL FOR A PROSPECTIVE COLLABORATIVE OVERVIEW OF ALL CURRENT AND PLANNED RANDOMIZED TRIALS OF CHOLESTEROL TREATMENT REGIMENS", The American journal of cardiology, 75(16), 1995, pp. 1130-1134
88. GULLESTAD L; NES M; RONNEBERG R; MIDTVEDT K; FALCH D; KJEKSHUS J
    MAGNESIUM STATUS IN HEALTHY FREE-LIVING ELDERLY NORWEGIANS
    Journal of the American College of Nutrition
    
    L. Gullestad et al., "MAGNESIUM STATUS IN HEALTHY FREE-LIVING ELDERLY NORWEGIANS", Journal of the American College of Nutrition, 13(1), 1994, pp. 45-50
89. HALL C; KJEKSHUS J; ENEROTH P; SNAPINN S
    THE PLASMA-CONCENTRATION OF N-TERMINAL PROATRIAL NATRIURETIC FACTOR ANF(1-98) IS RELATED TO PROGNOSIS IN SEVERE HEART-FAILURE
    Clinical cardiology
    
    C. Hall et al., "THE PLASMA-CONCENTRATION OF N-TERMINAL PROATRIAL NATRIURETIC FACTOR ANF(1-98) IS RELATED TO PROGNOSIS IN SEVERE HEART-FAILURE", Clinical cardiology, 17(4), 1994, pp. 191-195
90. ERIKSSON SV; ENEROTH P; KJEKSHUS J; OFFSTAD J; SWEDBERG K
    NEUROENDOCRINE ACTIVATION IN RELATION TO LEFT-VENTRICULAR FUNCTION INCHRONIC SEVERE CONGESTIVE-HEART-FAILURE - A SUBGROUP ANALYSIS FROM THE COOPERATIVE NORTH SCANDINAVIAN ENALAPRIL SURVIVAL STUDY (CONSENSUS)
    Clinical cardiology
    
    S.V. Eriksson et al., "NEUROENDOCRINE ACTIVATION IN RELATION TO LEFT-VENTRICULAR FUNCTION INCHRONIC SEVERE CONGESTIVE-HEART-FAILURE - A SUBGROUP ANALYSIS FROM THE COOPERATIVE NORTH SCANDINAVIAN ENALAPRIL SURVIVAL STUDY (CONSENSUS)", Clinical cardiology, 17(11), 1994, pp. 603-606
91. PEDERSEN TR; KJEKSHUS J; OLSSON AG; BERG K; FAERGEMAN O; HAGHFELT T; MIETTINEN T; PYORALA K; THORGEIRSSON G; WEDEL H; WILHELMSEN L
    SCANDINAVIAN SIMVASTATIN STUDY (4S) - REPLY
    Lancet
    
    T.R. Pedersen et al., "SCANDINAVIAN SIMVASTATIN STUDY (4S) - REPLY", Lancet, 344(8939-4), 1994, pp. 1767-1768
92. PEDERSEN TR; KJEKSHUS J; BERG K; HAGHFELT T; FAERGEMAN O; THORGEIRSSON G; PYORALA K; MIETTINEN T; WILHELMSEN L; OLSSON AG; WEDEL H; KRISTIANSON K; THOMSEN H; NORDERO E; THOMSEN B; LYNGBORG K; ANDERSEN GS; NIELSEN F; TALLERUPHUUS U; MCNAIR A; EGSTRUP K; SIMONSEN EH; SIMONSEN I; VEJBYCHRISTENSEN H; SOMMER L; EIDNER PO; KLARHOLT E; HENRIKSEN A; MELLEMGAARD K; LAUNBJERG J; FREUERGAARD P; NIELSEN L; MADSEN EB; IBSEN H; ANDERSEN U; ENEMARK H; HAARBO J; MARTINSEN B; DAHLSTROM CG; THYRRING L; THOMASSEN K; JENSEN G; RASMUSSEN SL; SKOV N; HANSEN KN; LARSEN ML; HAASTRUP B; HJAERE I; THUROE A; LETH A; MUNCH M; WORCK R; NIELSEN B; THORN AG; PEDERSENBJERGAARD O; FOURNAISE B; SIGURD B; ENK B; NIELSEN H; JACOBSEN L; SVENDSEN TL; HOEGHOLM A; MUNTER H; KAUFMANN P; HAUNSO S; GRANDE P; ERIKSEN C; NIELSEN HH; JURLANDER B; PINBORG T; PINDBORG J; TOST H; CHRISTIANSEN BD; OPPENHAGEN M; EGEDE F; HVIDT S; KJAERBY T; LEMMING L; KLAUSEN I; MIETTINEN TA; VANHANEN H; STRANDBERG TE; HOLTTA K; LUOMANMAKI H; PEKURI T; VUORINEN A; PASTERNACK A; OKSA H; SIITONEN L; RIMPI R; KESANIEMI YA; LILJA M; KORHONEN T; RANTALA A; RANTALA M; SAVOLAINEN M; UKKOLA O; LAINE L; VIRKKALA L; LEHTO S; MIETTINEN H; SALOKANNEL A; RAISANEN R; HOGNASON J; KRISTJANSDOTTIR H; THORVALDSDOTTIR G; SIGURDSSON G; SVERRISSON JT; HANSTEEN V; KJELSBERG F; BERGET K; PETTERSEN R; BALTO ER; HOLM T; GUNDERSEN T; ASLAKSEN B; ANDERSEN EH; TORSVIK H; FABER A; INDREBO T; OSE A; ROTERUD T; HOLSTLARSEN L; WAAGE K; HOLSTLARSEN E; HAEREM JW; AUKRUST P; TORP R; RISBERG K; MAUSETH K; GERDTS E; NYGARD O; HALLARAKER A; GRADEK G; VANGEN EM; SCHARTUMHANSEN H; REFSUM AM; LISTERUD S; GUNDERSRUD B; STENE AM; KLYKKEN B; AAKERVIK O; LORAAS A; FOSS PO; HAGA A; THORESEN L; DRIVENES A; LEM P; GABRIELSEN F; HESTAD S; RODE R; HAUG BK; SKJELVAN G; ELDORSEN E; YTREARNE K; RASMUSSEN K; MYHRE ESP; NERMOEN I; CHRISTIANSEN L; KARLSEN AS; WALBERG K; TJONNDAL HA; KULSENG B; ROKSETH R; NERGARD TV; ROE MO; TENSTAD O; LOFSNES IL; BERGSRUD U; MELBERG TH; VONBRANDIS C; BARVIK S; WOIE L; ABRAHAMSEN AM; AARSLAND T; SVANES H; NOER G; NORDLIE KE; HANEDALEN AE; JOHANSEN T; LARSEN CB; OSTHOLM E; OVERSKEID K; SANDVEI P; JOHANSEN A; SOGNEN E; AARSKOG D; DALE A; HEGRESTAD S; REIKVAM A; HAWKES L; HOFF S; TORJUSSEN T; NORVIK R; JORGENSEN C; HJERMANN I; LEREN P; NARVESTAD A; FAUSA D; GJESTVANG FT; NORDLAND B; BRUNMARK P; BIOKLUND H; BIOKLUND B; FORSBERG H; BERGSTROM B; LAAKSONEN I; VESTERMARK MB; MASCHER G; HAMMARSTROM E; TROSELL K; KARLSSON L; HALLSTROM L; STJERNA A; SLETTE MK; DIDERHOLM E; PBERGLUND K; LINDE B; AHLMARK G; SAETRE H; AHLBERG G; SUNDKVIST K; GUSTAFSSON PE; GUSTAFSSON E; NORRBY A; JAUP B; SVENSSON L; WIKLUND O; LINDEN T; BERGH CH; JONSTEG K; BONNIER B; LUNDIN Y; ROMANUS K; ULVENSTAM G; JOHANSSON S; WALLIN I; DUDAS K; ANDREASSON M; TORELUND G; SKARFORS E; RUTER G; AKESSON L; WAGNER F; LJUNGDAHL L; WAGNER V; RASMANIS G; EDHAG O; VOURISALO D; HJELMSELL H; WESLEY G; LUNDKVIST L; ANGMAN K; OLSSON A; SVENSON O; KUYLENSTIERNA J; FRISENETTEFICH K; BERGMAN E; STROMBLAD H; JENSEN S; JONSSON E; LEVIN C; ODEBERG H; BENGTSSON PO; HOLMESSON E; HEDSTRAND H; BOJO L; OBERG S; LEKSELL H; WERNER P; PERSSON S; SIMONSSON M; WIRENSTAM UB; MOBERG B; EKSTRAND AB; NICOL P; MALMROS B; SAAW J; ARCINI N; KOBOSKO J; ANEVIK IG; GYLAND F; LUNDH B; WENNERHOLM M; OLSSON C; KJELLBERG J; FABIANSON K; FRASER T; BERGKVIST I; BERGDAHL B; FLUUR C; WAJERSTAM S; SVENSSON KA; EKHOLM L; TOREBO E; RYBERG A; FRISELL JE; HEDMAN A; WALLRUP L; ANDERSEN G; SANDSTROM M; ALBERG K; FAGHER B; THULIN T; SVENSTAM I; BJURMAN A; SKOGLUND E; DAHL G; KJELLSTROM T; JUHLIN P; SJOOBOQUIST M; SJOGREN A; LOOGNA E; JANSSON T; FRIDEN J; NILSSON O; ANDERSSON PO; HENRIKSSON C; ELLSTROM J; BRODERSSON H; LUNDQUIST L; ASLUND M; BOMAN K; JANSSON JH; NORRFORS B; HOGLUND C; LUNDBLAD M; LILJEFORS I; WENNERSTROM L; PERZ I; LEIJD B; FALKENBERG C; BERGSTEN L; STROM S; ENGSTROM AC; EJDEBACK J; MALMBERG K; HOGSTROM S; STAHL L; MOLLER BH; LYCKSELL M; SODERSTROM M; HANSSON E; HALLEN C; STAKEBARG H; BORRETZEN J; HEDEN B; ANDERSSON K; JOHNSON O; BIRGANDER LS; ELANDER B; LIDELL C; ANDERSSON PE; MARKLUND E; DAHLEN M; RUCKER F; LOFQVIST M; WANNBERG B; LIM BH; LARSSON O; ANDERSSON G; HANSSON A; UCHTO M; GOWENIUS M; UGGELDAHL I; URSING D; HAMMARLUND P; NYMAN P; TSUPPUKA E; MALMBERG L; GORANSSON K; HASSELGREN P; INSBERG CM; PETTERSON S; AHRLIN A; LOVHEIM O; ANDERSSON LO; GRUNDSTROM I
    RANDOMIZED TRIAL OF CHOLESTEROL-LOWERING IN 4444 PATIENTS WITH CORONARY-HEART-DISEASE - THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S)
    Lancet
    
    T.R. Pedersen et al., "RANDOMIZED TRIAL OF CHOLESTEROL-LOWERING IN 4444 PATIENTS WITH CORONARY-HEART-DISEASE - THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S)", Lancet, 344(8934), 1994, pp. 1383-1389
93. GULLESTAD L; MIDTVEDT K; DOLVA LO; NORSETH J; KJEKSHUS J
    THE MAGNESIUM LOADING TEST - REFERENCE VALUES IN HEALTHY-SUBJECTS
    Scandinavian journal of clinical & laboratory investigation
    
    L. Gullestad et al., "THE MAGNESIUM LOADING TEST - REFERENCE VALUES IN HEALTHY-SUBJECTS", Scandinavian journal of clinical & laboratory investigation, 54(1), 1994, pp. 23-31
94. ERIKSSON SV; KJEKSHUS J; OFFSTAD J; SWEDBERG K
    PATIENT CHARACTERISTICS IN CASES OF CHRONIC SEVERE HEART-FAILURE WITHDIFFERENT DEGREES OF LEFT-VENTRICULAR SYSTOLIC DYSFUNCTION
    Cardiology
    
    S.V. Eriksson et al., "PATIENT CHARACTERISTICS IN CASES OF CHRONIC SEVERE HEART-FAILURE WITHDIFFERENT DEGREES OF LEFT-VENTRICULAR SYSTOLIC DYSFUNCTION", Cardiology, 85(3-4), 1994, pp. 137-144
95. GULLESTAD L; BIRKELAND K; MOLSTAD P; HOYER MM; VANBERG P; KJEKSHUS J
    THE EFFECT OF MAGNESIUM VERSUS VERAPAMIL ON SUPRAVENTRICULAR ARRHYTHMIAS
    Clinical cardiology
    
    L. Gullestad et al., "THE EFFECT OF MAGNESIUM VERSUS VERAPAMIL ON SUPRAVENTRICULAR ARRHYTHMIAS", Clinical cardiology, 16(5), 1993, pp. 429-434
96. HUNT D; VARIGOS J; DIENSTL F; LECHLEITNER P; DEBACKER G; KORNITZER M; CAIRNS J; TURPIE A; FRITZHANSEN P; SKAGEN K; KALA R; HEIKKILA J; BOISSEL JP; LEIZOROVICZ A; SCHRODER R; KOTHE K; KARATZAS N; HORGAN J; OCALLAGHAN D; TOGNONI G; FRANZOSI MG; MAGGIONI A; COHEN A; KOSTER R; WHITE H; MACMAHON S; KJEKSHUS J; REIKVAM A; CEREMUZYNSKI L; PAOLASSO E; DIAZ R; VALENTIN V; WILHELMSEN L; LUNDKVIST L; MOCCETTI T; MALACRIDA R; GENONI M; COLLINS R; SLEIGHT P; PETO R; PARISH S; DOLL R; ARMITAGE P; CEDERHOLMWILLIAMS S; CONWAY M; DOVE P; FLATHER M; MARSHALL J; YOUNGMAN L; JULIAN D; CHAMBERLAIN D; WARLOW C; SANDERCOCK P; FOX K; HENNEKENS C; GOLDHABER S; TIMMIS G; YUSUF S; MEIER P
    ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION
    Lancet
    
    D. Hunt et al., "ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION", Lancet, 339(8796), 1992, pp. 753-770